Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Juvederm

- PMLiVE

Size matters?

Pfizer’s $160bn deal to acquire Allergan will challenge the new company to show that big is better

Deal Watch January 2016

Shire, Roche, Sanofi, BMS and Merck & Co are among those featured in this month's roundup of M&A and other pharma deal activity

The future of Pfizer(s)

Current headlines point to a frightening journey

- PMLiVE

Pfizer to form specialty drugs unit after Allergan takeover

Will merge its consumer portfolio with Allergan's ophthalmology and aesthetics brands

- PMLiVE

Zeno Group acquires 3 Monkeys Communications

Strikes deal as a part of the agency’s continued global expansion

- PMLiVE

2015’s ‘premium’ prices dissuaded J&J from acquisitions, says Gorsky

More M&A activity anticipated in 2016 and beyond

- PMLiVE

Acorda acquires Biotie to expand in Parkinson’s disease

Strikes $363m deal for Finnish firm

Weber Shandwick acquires US healthcare communications firm

Strikes deal with ReviveHealth in bid to boost its integrated health comms services

Deal Watch December 2015

The month’s deals see a number of collaboration and licensing deals for technology platforms and new molecule discovery

Shire Basingstoke

Shire deal with Baxalta predicted this week

Takeover talks reported to be at an advanced stage

- PMLiVE

AZ takes majority stake in cancer drug developer Acerta

Will pay $4bn for a 55% share in the Dutch biopharma company

Deal Watch November 2015

Strategic business expansion or financial engineering?In November Pfizer at long last found a willing acquisition target that may provide the tax inversion it has been desperate to achieve since its...

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links